4 MENORAT HAMAOR ST., TEL AVIV, L3
InspireMD, Inc. Enters $75 Million Equity Distribution Agreement with BTIG
Reports Fourth Quarter and Full Year 2025 Financial Results
COO Departure - Andrea Tommasoli Dismissed from InspireMD, Inc.
Director Resignation - Kathryn Arnold Steps Down from InspireMD Board
Investor Presentation
Announces the Appointment of Dan Dearen to its Board of Directors
Amended material disclosure
Reports Second Quarter 2025 Financial Results
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload